Blood & Cancer

Introducing Run the List: the latest hem onc news - Earlier lung screening doubles eligibility, lifestyle reduces breast cancer risk regardless of genetics, FDA approves MDS/CMML drug, COVID mask exemptions

Informações:

Sinopsis

The latest news for hematology and oncology professionals. In this episode:  USPSTF: Earlier lung cancer screening can double eligibility * Review and comment on the USPSTF site: https://bit.ly/3fppiD7* National Lung Screening Trial https://bit.ly/2CvNRQt  Lifestyle choices may reduce breast cancer risk regardless of genetics* Read the article on MDedge: https://bit.ly/2ZrsWqN * Read the original research: https://bit.ly/3etRLGx (JAMA Netw Open. 2020;3(4):e203760). FDA approves oral therapy for myelodysplastic syndromes, CMML * Read the FDA news release: https://bit.ly/2WeUIVb Commentary: 'Doc, Can I Get a Mask Exemption?' * Read the full commentary from Dr. Rizzo: https://wb.md/2Wfoh9i* Read the CDC Recommendations: https://bit.ly/304OTed * Read more about Dr. Albert Rizzo: https://bit.ly/3j2QDgW For more MDedge Podcasts go to https://www.mdedge.com/podcasts/ Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgeHemOnc